AN2 Therapeutics Inc

NASDAQ ANTX

Data sourced from iex and EODHD
Download Data

AN2 Therapeutics Inc Cash Flow Statement 2021 - 2024

This table shows the Cash Flow Statement for AN2 Therapeutics Inc going from 2021 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31
Net Income
M -66 -65 -60 -54 -49 -41 -37 -32 -27 -22 -14 -7 -2
Depreciation and Amortization
M 0 0 -1 -2 -1 -1 0 0 0 - - - -
Non-Cash Items (Other)
M -1 -2 -1 0 0 0 0 0 0 0 0 0 -
Operating Cash Flow
M -59 -53 -44 -42 -38 -33 -35 -30 -26 -20 -11 -7 -2
Capital Expenditures
M 0 0 0 0 0 -1 -1 -1 -1 -1 -1 -1 -1
Net Acquisitions
M - - - - - - - - - - - - -
Other Investing Activities
M - - - - - - - - - - - - -
Investing Cash Flow
M - - - - - - - - - - - - -
Repayment/Issuance of Debt (Net)
M - - - - - - - - - - - - -
Equity Repurchase (Common, Net)
M 0 0 0 0 0 - - - - - - - -
Dividends Paid
M - - 2 2 4 5 4 4 2 - - - -
Other Financial Activities
M 20 1 21 18 12 3 0 2 -49 29 30 30 80
Financing Cash Flow
M 20 1 21 18 12 3 0 2 -49 29 30 30 80
Exchange Rate Adjustment
M - - - - - - - - - - - - -
Beginning Cash
M 16 33 41 27 27 29 41 83 12 16 28 82 4
Ending Cash
M 25 16 33 41 27 27 29 41 83 12 16 28 82
Stock-Based Compensation
M 9 8 8 7 6 4 3 2 1 1 1 0 0
Issuance/Purchase of Shares
M 0 0 0 0 0 - - - - - - - -
Capital Stock Change
M 85 85 85 19 7 70 70 70 63 0 0 0 -
Working Capital
M 401 377 372 363 389 422 387 284 171 57 - - -
Free Cash Flow
M -59 -53 -44 -42 -38 -33 -35 -30 -26 -20 -11 -7 -2

StockViz Staff

September 19, 2024

Any question? Send us an email